HEDS is part of the School of Health and Related Research (ScHARR) at the University of Sheffield. We undertake research, teaching, training and consultancy on all aspects of health related decision science, with a particular emphasis on health economics, HTA and evidence synthesis.

Monday, 30 October 2017

HEDS research as a special edition of PharmacoEconomics

HEDS have contributed no-less than nine articles to a comprehensive compilation for a PharmacoEconomics special edition. The papers are robust recommendations in sourcing and using appropriate health state utility values in economic models in health care. 

Image of PharmacoEconomics Journal
© Springer
They are intended as a reference source for state of the art evidence on good practice across the full spectrum of needs associated with health state utility values that inform decision analytic models. The articles cover international regulations for utility values for health technology assessment, generic preference-based measures, condition-specific preference-based measures, identifying, reviewing and synthesizing utility values from the literature, mapping, collecting utility values in clinical studies, using utility values in decision models, and estimating utility values for comorbidities. The papers have emerged from a collaboration between academics at Sheffield University and experts from industry (at Takeda Pharmaceuticals). 

Andrew Lloyd who wrote the editorial for the special edition said: "This is an informative set of papers that will be useful for anyone working in the fields of pharmacoeconomics and health technology assessment."

The nine papers were authored by Professor John Brazier, Dr Donna Rowen, Roberta Ara, Dr Clara Mukuria, Dr Tessa Peasgood, Dr Tracey Young, Dr Suzy Paisley alongside external collaborators.

The Role of Condition-Specific Preference-Based Measures in Health Technology Assessment